Substance P and neutral endopeptidase in development of acute respiratory distress syndrome following fire smoke inhalation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 4 31-4, 2004, Pages

  Wong, Simon S ^a,b   Sun, Nina N ^a   Lantz, R Clark ^a   Witten, Mark L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Acute lung injury; Neurogenic inflammation; Neurokinin 1 receptor

Indexed keywords

ALBUMIN; HYDROLASE; MEMBRANE METALLOENDOPEPTIDASE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NOLPITANTIUM; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL DAMAGE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; EXTRAVASATION; FEMALE; FIRE; HYPOXEMIA; LUNG BURN; LUNG EDEMA; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY EPITHELIUM; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOOD GAS ANALYSIS; DISEASE MODELS, ANIMAL; FIRES; HUMANS; KINETICS; NEPRILYSIN; RATS; RATS, INBRED F344; RESPIRATORY DISTRESS SYNDROME, ADULT; SMOKE; SUBSTANCE P; TIME FACTORS;

EID: 4544325807     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00388.2003     Document Type: Article

References (51)

1. Ansel JC, Brown JR, Payan DG, and Brown MA. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 150: 4478-4485, 1993.
2. Bang R, Sass G, Kiemer AK, Vollmar AM, Neuhuber WL, and Tiegs G. Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury. J Pharmacol Exp Ther 305: 31-39, 2003.
3. Barnes PJ. Airway inflammation and autonomic control. Eur J Respir Dis Suppl 147: 80-87, 1986.
4. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, and Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824, 1993.
5. Bhatia M, Saluja AK, Hofbauer B, Frossard JL, Lee HS, Castagliuolo I, Wang CC, Gerard N, Pothoulakis C, and Steer ML. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci USA 95: 4760-4765, 1998.
6. Bozic CR, Lu B, Hopken UE, Gerard C, and Gerard NP. Neurogenic amplification of immune complex inflammation. Science 273: 1722-1725, 1996.
7. Brain JD, Long NC, Wolfthal SF, Dumyahn T, and Dockery DW. Pulmonary toxicity in hamsters of smoke particles from Kuwaiti oil fires. Environ Health Perspect 106: 141-146, 1998.
8. Brunelleschi S, Tarli S, Giotti A, and Fantozzi R. Priming effects of mammalian tachykinins on human neutrophils. Life Sci 48: PL1-PL5, 1991.
9. Brunelleschi S, Vanni L, Ledda F, Giotti A, Maggi CA, and Fantozzi R. Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors. Br J Pharmacol 100: 417-420, 1990.
10. Chiba Y and Misawa M. Inhibition of neutral endopeptidase increases airway responsiveness to ACh in nonsensitized normal rats. J Appl Physiol 78: 394-402, 1995.
11. Cuesta MC, Quintero L, Pons H, and Suarez-Roca H. Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells. Neurochem Int 40: 301-306, 2002.
12. Dianzani C, Lombardi G, Collino M, Ferrara C, Cassone MC, and Fantozzi R. Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils. J Leukoc Biol 69: 1013-1018, 2001.
13. Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, Traber L, Phillips GB, Parkinson JF, Cox R, Hawkins H, Herndon D, and Traber DL. The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury. Am J Respir Crit Care Med 167: 1021-1026, 2003.
14. Espiritu RF, Pittet JF, Matthay MA, and Goetzl EJ. Neuropeptides in pulmonary edema fluid of adult respiratory distress syndrome. Inflammation 16: 509-517, 1992.
15. Fontan JJ, Cortright DN, Krause JE, Velloff CR, Karpitskyi VV, Carver TW Jr, Shapiro SD, and Mora BN. Substance P and neurokinin-1 receptor expression by intrinsic airway neurons in the rat. Am J Physiol Lung Cell Mol Physiol 278: L344-L355, 2000.
16. Grady EF, Garland AM, Gamp PD, Lovett M, Payan DG, Bunnett NW. Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. Mol Biol Cell 6: 509-524, 1995.
17. Guo CJ, Lai JP, Luo HM, Douglas SD, and Ho WZ. Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes. J Neuroimmunol 131: 160-167, 2002.
18. Hales CA, Barkin PW, Jung W, Trautman E, Lamborghini D, Herrig N, and Burke J. Synthetic smoke with acrolein but not HCl produces pulmonary edema. J Appl Physiol 64: 1121-1133, 1988.
19. Hales CA, Elsasser TH, Ocampo P, and Efimova O. TNF-alpha in smoke inhalation lung injury. J Appl Physiol 82: 1433-1437, 1997.
20. Inoue N, Magari S, and Sakanaka M. Distribution of peptidergic nerve fibers in rat bronchus-associated lymphoid tissue: light microscopic observations. Lymphology 23: 155-160, 1990.
21. Iwamoto I, Nakagawa N, Yamazaki H, Kimura A, Tomioka H, and Yoshida S. Mechanism for substance P-induced activation of human neutrophils and eosinophils. Regul Pept 46: 228-230, 1993.
22. Iwamoto I, Yamazaki H, Nakagawa N, Kimura A, Tomioka H, and Yoshida S. Differential effects of two C-terminal peptides of substance P on human neutrophils. Neuropeptides 16: 103-107, 1990.
23. Kanazawa H, Hirata K, and Yoshikawa J. Administration of SIN-1 induces guinea pig airway hyperresponsiveness through inactivation of airway neutral endopeptidase. Int Arch Allergy Immunol 120: 317-322, 1999.
24. Kimmel EC and Still KR. Acute lung injury, acute respiratory distress syndrome and inhalation injury: an overview. Drug Chem Toxicol 22: 91-128, 1999.
25. Kimura R, Traber LD, Herndon DN, Linares HA, Lubbesmeyer HJ, and Traber DL. Increasing duration of smoke exposure induces more severe lung injury in sheep. J Appl Physiol 64: 1107-1113, 1988.
26. Kimura R, Traber LD, Herndon DN, Neuhaus GD, and Traber DL. Treatment of smoke-induced pulmonary injury with nebulized dimethylsulfoxide. Circ Shock 25: 333-341, 1988.
27. Kou YR, Wang CY, and Lai CJ. Role of vagal afferents in the acute ventilatory responses to inhaled wood smoke in rats. J Appl Physiol 78: 2070-2078, 1995.
28. Koyama S, Sato E, Nomura H, Kubo K, Nagai S, and Izumi T. Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activity. J Appl Physiol 84: 1528-1534, 1998.
29. Laffon M, Pittet JF, Modelska K, Matthay MA, and Young DM. Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits. Am J Respir Crit Care Med 160: 1443-1449, 1999.
30. Lai CJ and Kou YR. Stimulation of vagal pulmonary C fibers by inhaled wood smoke in rats. J Appl Physiol 84: 30-36, 1998.
31. Lee LY and Widdicombe JG. Modulation of airway sensitivity to inhaled irritants: role of inflammatory mediators. Environ Health Perspect 109, Suppl 4: 585-589, 2001.
32. Lilly CM, Drazen JM, and Shore SA. Peptidase modulation of airway effects of neuropeptides. Proc Soc Exp Biol Med 203: 388-404, 1993.
33. Lloyds D and Hallett MB. Activation and priming of the human neutrophil oxidase response by substance P: distinct signal transduction pathways. Biochim Biophys Acta 175: 207-213, 1993.
34. Maa J, Grady EF, Yoshimi SK, Drasin TE, Kim EH, Hutter MM, Bunnett NW, and Kirkwood KS. Substance P is a determinant of lethality in diet-induced hemorrhagic pancreatitis in mice. Surgery 128: 232-239, 2000.
35. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, Leppert M, Matalon S, Munford R, Parsons P, Slutsky AS, Tracey KJ, Ward P, Gail DB, and Harabin AL. Future research directions in acute lung injury: summary of a national heart, lung, and blood institute working group. Am J Respir Crit Care Med 167: 1027-1035, 2003.
36. Matthew E, Warden G, and Dedman J. A murine model of smoke inhalation. Am J Physiol Lung Cell Mol Physiol 280: L716-L723, 2001.
37. Murris-Espin M, Pinelli E, Pipy B, Leophonte P, and Didier A. Substance P and alveolar macrophages: effects on oxidative metabolism and eicosanoid production. Allergy 50: 334-339, 1995.
38. Schmalstieg FC, Chow J, Savage C, Rudloff HE, Palkowetz KH, and Zwischenberger JB. Interleukin-8, aquaporin-1, and inducible nitric oxide synthase in smoke and burn injured sheep treated with percutaneous carbon dioxide removal. ASAIO J 47: 365-371, 2001.
39. Serra MC, Calzetti F, Ceska V, and Cassatella MA. Effect of substance P on superoxide anion and IL-8 production by human PMNL. Immunology 82: 63-69, 1994.
40. Sterner-Kock A, Braun R, van der Vliet A, Schrenzel M, McDonald R, Kabbur M, Vulliet R, and Hyde D. Substance P primes the formation of hydrogen peroxide and nitric oxide in human neutrophils. J Leukoc Biol 65: 834-840, 1999.
41. Stretton D. Non-adrenergic, non-cholinergic neural control of the airways. Clin Exp Pharmacol Physiol 18: 675-684, 1991.
42. Tripp RA, Barskey A, Goss L, and Anderson LJ. Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection. J Neuroimmunol 129: 141-153, 2002.
43. Veronesi B, Carter JD, Devlin RB, Simon SA, and Oortgiesen M. Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line. Neuropeptides 33: 447-456, 1999.
44. Wang S, Lantz RC, Chen GJ, Breceda V, Rider E, Hays AM, Parliman G, Tollinger BJ, Robledo RF, Kunke K, Tinajero J, and Witten ML. The prophylactic effects of U75412E pretreatment in a smoke-induced lung injury rabbit model. Pharmacol Toxicol 79: 231-237, 1996.
45. Wang S, Lantz RC, Rider ED, Chen GJ, Breceda V, Hays AM, Robledo RF, Tollinger BJ, Dinesh SV, and Witten ML. A free radical scavenger (Lazaroid U75412E) attenuates tumor necrosis factor-alpha generation in a rabbit model of smoke-induced lung injury. Respiration 64: 358-363, 1997.
46. Wang S, Lantz RC, Robledo RF, Breceda V, Hays AM, and Witten ML. Early alterations of lung injury following acute smoke exposure and 21-aminosteroid treatment. Toxicol Pathol 27: 334-341, 1999.
47. Wang S, Lantz RC, Vermeulen MW, Chen GJ, Breceda V, Robledo RF, Hays AM, Young S, and Witten ML. Functional alterations of alveolar macrophages subjected to smoke exposure and antioxidant lazaroids. Toxicol Ind Health 15: 464-469, 1999.
48. Wang S, Lantz RC, and Witten ML. Substance P and other mediators in a rabbit model of acute respiratory distress syndrome (Abstract). Toxicol Sci 54: 139, 2000.
49. Ware LB and Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
50. Wong SS, Sun NN, Keith I, Kweon CB, Foster DE, Schauer JJ, and Witten ML. Tachykinin substance P signaling involved in diesel exhaust-induced bronchopulmonary neurogenic inflammation in rats. Arch Toxicol 77: 638-650, 2003.
51. Wozniak A, McLennan G, Betts WH, Murphy GA, and Scicchitano R. Activation of human neutrophils by substance P: effect on FMLP-stimulated oxidative and arachidonic acid metabolism and on antibody-dependent cell-mediated cytotoxicity. Immunology 68: 359-364, 1989.